During the COLYM 2022 Annual Meeting, the Lymphoma Hub spoke with Kieron Dunleavy, The George Washington Cancer Center, Washington, DC, US. We asked, What are the current treatment options for double-hit lymphoma?
Dunleavy reviews outcome data for the intensive regimens used to treat double-hit lymphoma and makes comparisons to those used for Burkitt lymphoma. Dunleavy compares the challenges that older patients undergoing intensive treatment therapies face compared with younger patients and discusses novel treatment options for high-grade B-cell lymphomas, such as anti-CD19 CAR T cells.
7 окт 2024